Skip to content

Clinical trials

Phase 3 Uterine Cervical Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 3 Country / region: China Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20112
20123
20154
20162
20171
20182
20192
20206
202112
20229
20231
20245
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status18
Completed12
Recruiting12
Active, not recruiting7
Terminated2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Bovax Biotechnology Co., Ltd.6
Sun Yat-sen University6
Xiamen University4
Huazhong University of Science and Technology3
Lei Li2
Merck Sharp & Dohme LLC2
Peking Union Medical College Hospital2
Sichuan Cancer Hospital and Research Institute2
Suzhou Suncadia Biopharmaceuticals Co., Ltd.2
xie congying2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms53
Condylomata Acuminata11
Papillomavirus Infections6
Vaginal Neoplasms6
Vulvar Neoplasms5
Uterine Cervical Dysplasia4
Endometrial Neoplasms2
Fallopian Tube Neoplasms2
Ovarian Neoplasms2
Persistent Infection2

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.